JP2020501521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020501521A5 JP2020501521A5 JP2019524202A JP2019524202A JP2020501521A5 JP 2020501521 A5 JP2020501521 A5 JP 2020501521A5 JP 2019524202 A JP2019524202 A JP 2019524202A JP 2019524202 A JP2019524202 A JP 2019524202A JP 2020501521 A5 JP2020501521 A5 JP 2020501521A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- variant
- linked
- derivative
- isolated protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016904572A AU2016904572A0 (en) | 2016-11-09 | Subtilase cytotoxin b subunit mutant | |
| AU2016904572 | 2016-11-09 | ||
| PCT/AU2017/051230 WO2018085888A1 (en) | 2016-11-09 | 2017-11-09 | Subtilase cytotoxin b subunit mutant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020501521A JP2020501521A (ja) | 2020-01-23 |
| JP2020501521A5 true JP2020501521A5 (enExample) | 2020-12-17 |
| JP7123921B2 JP7123921B2 (ja) | 2022-08-23 |
Family
ID=62109062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524202A Active JP7123921B2 (ja) | 2016-11-09 | 2017-11-09 | サブチラーゼサイトトキシンｂサブユニット変異体 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11371033B2 (enExample) |
| EP (1) | EP3538544B1 (enExample) |
| JP (1) | JP7123921B2 (enExample) |
| KR (1) | KR102703633B1 (enExample) |
| CN (1) | CN110402251A (enExample) |
| AU (1) | AU2017358401B2 (enExample) |
| CA (1) | CA3044303A1 (enExample) |
| ES (1) | ES2983352T3 (enExample) |
| WO (1) | WO2018085888A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112760305B (zh) * | 2021-01-25 | 2022-04-29 | 浙江工业大学 | 一种栖热腔菌磷酸酶突变体及其应用 |
| CN117651868A (zh) * | 2021-05-06 | 2024-03-05 | 伊诺维吉股份有限公司 | 与肿瘤源性胞外囊泡相关的方法 |
| WO2022236383A1 (en) * | 2021-05-14 | 2022-11-17 | The University Of Adelaide | Methods of analysing a sample |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO007396A0 (en) | 1996-05-24 | 1996-06-20 | Csl Limited | Ebv ctl epitopes |
| AUPO784197A0 (en) | 1997-07-10 | 1997-08-07 | Csl Limited | Treatment of nasopharyngeal carcinoma |
| EP1386927B1 (en) | 2002-08-02 | 2005-03-30 | Institut Curie | Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors |
| US7078489B2 (en) * | 2003-12-22 | 2006-07-18 | Adelaide Research & Innovation Pty, Ltd. | Cytotoxin with a subtilase domain |
| EP2667898A1 (en) | 2011-01-26 | 2013-12-04 | Cenix Bioscience GmbH | Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes |
-
2017
- 2017-11-09 EP EP17870370.8A patent/EP3538544B1/en active Active
- 2017-11-09 US US16/348,732 patent/US11371033B2/en active Active
- 2017-11-09 CN CN201780082403.7A patent/CN110402251A/zh active Pending
- 2017-11-09 CA CA3044303A patent/CA3044303A1/en active Pending
- 2017-11-09 WO PCT/AU2017/051230 patent/WO2018085888A1/en not_active Ceased
- 2017-11-09 ES ES17870370T patent/ES2983352T3/es active Active
- 2017-11-09 JP JP2019524202A patent/JP7123921B2/ja active Active
- 2017-11-09 AU AU2017358401A patent/AU2017358401B2/en active Active
- 2017-11-09 KR KR1020197014900A patent/KR102703633B1/ko active Active
-
2022
- 2022-05-27 US US17/827,072 patent/US20220372459A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7573437B2 (ja) | 膜タンパク質を使用する治療用エクソソームの調製 | |
| TWI599367B (zh) | Ｈｌａ-ａ*１１０１限制性ｗｔ１胜肽之用途 | |
| TWI751973B (zh) | 用於對抗卵巢癌及其他癌症之免疫治療的新穎胜肽及胜肽組合物 | |
| Fairhead et al. | SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly | |
| JP2018521641A (ja) | 卵巣がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチドの組み合わせ | |
| JP2016524592A5 (enExample) | ||
| JP2022028646A (ja) | 免疫調節化合物 | |
| JP2016519932A5 (enExample) | ||
| JP2015530404A5 (enExample) | ||
| DK1759013T3 (da) | Identificering af overflade-associerede antigener til tumordiagnose | |
| CN119060129A (zh) | 用于头颈鳞状细胞癌和其他癌症免疫治疗的新型肽和支架 | |
| JP2017536337A5 (enExample) | ||
| HK1210713A1 (en) | Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof | |
| JP2020501521A5 (enExample) | ||
| JP2015057387A (ja) | クロスベータ構造体でのタンパク質の凝集の標的化誘導 | |
| RU2012137304A (ru) | Рекомбинантные белки для применения в вакцине, антитела к указанным белкам и диагностические и терапевтические способы, включающие указанное | |
| CN111138521A (zh) | 源自于afp抗原的短肽 | |
| CN114404582B (zh) | 通过分枝杆菌特异性免疫治疗肿瘤的方法及使用的抗原肽 | |
| KR20240161969A (ko) | 종양 항원, 종양 항원 kras, tpx2 또는 aurka을 포함하는 화합물 및 그 용도 | |
| CN108250289B (zh) | 源自于mage b6的肿瘤抗原短肽 | |
| Mohammed et al. | Protein Engineering and Drug Discovery: Importance, Methodologies, Challenges, and Prospects. Biomolecules 2025, 15, 1628 | |
| Zhang et al. | Synergetic protein factors that improve rhGM-CSF absorption via an oral route exist in silkworm pupae | |
| Smyrniotou et al. | 2-Oxoamides based on dipeptides and pseudodipeptides as inhibitors of Ca2+-independent phospholipase A2 | |
| CN108203459A (zh) | 源自于prame的肿瘤抗原短肽 | |
| TW201703795A (zh) | 白點症病毒vp31及層黏蛋白受體結合蛋白用於製造預防或治療白點症病毒感染的藥物的用途、及其組成物 |